Report on the 1^st ECCO-ESGAR Basic Imaging Workshop – Endoscopy Portion

Marietta Iacucci  © ECCO

Giovanni Maconi  © ECCO

Participating speakers and chairs: Raf Bisschops (Leuven, Belgium), Paulo Kotze (Curitiba, Brazil), Federica Furfaro (Milan, Italy), James East (Oxford, United Kingdom), Matt Rutter (North Tees, United Kingdom), Marietta Iacucci  (Birmingham, United Kingdom), Taku Kobayashi  (Tokyo, Japan), Filip Baert  (Roselare, Belgium), Krisztina Gecse (Amsterdam, the Netherlands), Henit Yanai (Petah Tikva, Israel) and James Lindsay (London, United Kingdom)

Giovanni Maconi  © ECCO

Christian Maaser  © ECCO

Participating speakers and chairs: Antonio López-Sanromán (Madrid, Spain), Giovanni Maconi (Milan, Italy), Jordi Rimola (Barcelona, Spain), Torsten Kucharzik (Lüneburg, Germany), Stephan Vavricka (Zurich, Switzerland), Christian Maaser (Lüneburg, Germany), Rune Wilkens (Copenhagen, Denmark).

Pascal Juillerat  © ECCO

Henit Yanai  © ECCO

The 17th Intensive Advanced IBD Course took place before the ECCO Congress as the highlight of the educational programme, which runs in conjunction with the Congress.

This well-known course, which has been held regularly almost since the inception of ECCO, took place once again at the 14th Congress of ECCO, attracting a full attendance from Europe and beyond. Overall, 87 doctors from 41 countries participated and were treated to a comprehensive update on IBD. 

Marieke Pierik © ECCO

The mission of the Epidemiological Committee of ECCO is optimisation of epidemiological research methods in Europe. During the ECCO Congress in Copenhagen, EpiCom said goodbye to Laurent Beaugerie and Nynne Nyboe-Andersen. We greatly thanked them for all their contributions to EpiCom and welcomed two new members from two different countries: the Netherlands and France.  

Krisztina Gecse © ECCO

It was our pleasure to welcome three new members, Laurent Beaugerie, Peter Bossuyt and Shaji Sebastian, onto the Clinical Research Committee of ECCO at the ECCO’19 Copenhagen Congress.

Sebastian Zeissig © ECCO

Mechanisms and therapeutic modulation of mucosal healing in IBD 

We saw one of the best-ever attended SciCom Workshops this year, with exciting talks and highly interactive discussions around the topic of mucosal healing in IBD. In two sessions, the mechanisms of intestinal regeneration and its disruption in IBD and novel approaches to the clinical assessment and therapeutic modulation of mucosal healing were discussed.

Another record number of abstracts has been submitted for the 14^th Congress of ECCO. Out of 1,222 submitted scientific abstracts, 1,012 abstracts have been accepted.

Of these abstracts, 38 have been selected as Oral Presentations during the Scientific Programme and another 90 were selected as Digital Oral Presentations. ECCO Committee Members reviewed each of these presentations to select the winners of the Top 10 DOPs, IIS Abstract Awards, and the Y-ECCO Abstract Awards.

8,034 delegates attended the 14th Congress of ECCO in Copenhagen

The 14^th Congress of ECCO – Inflammatory Bowel Diseases 2019, held on March 6-9, 2019 in Copenhagen, Denmark, attracted a total number of 8,034 delegates from 98 different countries. Since the inaugural ECCO Congress in 2006 in Amsterdam, at which there were 350 delegates, participant numbers have steadily increased, as shown in the graph below:

ECCO Congress participation 2006-2019 © ECCO

Willem Bemelman  © ECCO

Nuha Yassin  © ECCO

Ignacio Catalán-Serra © Ignacio Catalán-Serra

ECCO’19 Copenhagen welcomed the record number of participants – 8034 – by offering the three-day Scientific Programme “Research drives clinical care”, 16 educational courses, and a poster exhibition of 860 hard copy posters, as well as a platform for 45 exhibitors and for innumerable business meetings.

One of these meetings also brought the new ECCO News Editors team together in order to plan for the publication year 2019.

Giovanni Maconi © ECCO

Modern diagnostic imaging is no longer being employed purely in a diagnostic role in IBD, in order to confirm or exclude the disease and its complications; rather, it is now becoming a crucial aid in the management of patients, in particular for the tailoring and monitoring of therapy. Thus, alongside diagnostic indications ranging from early diagnosis to the detection of abdominal complications, imaging techniques are increasingly being used for the assessment and prediction of many other factors, including evaluation of response to treatment both early after its introduction (as part of the step-up approach to treatment) and in the long term (to assist in decision making with respect to exit strategies, e.g. by helping to determine the right time to suspend a biological therapy in patients successfully treated over a long period).